freephone 0800 862 0373
Sign in to view your quotes
Email address:
Password or PIN:

Forgotten your password? Reset it here.

Adding Avastin to chemotherapy helps slow ovarian cancer progression

Published on 12/06/2012

Adding cancer drug Avastin to chemotherapy helps slow progression of ovarian cancer, according to a new study.

Avastin is designed to shut down blood vessels that fuel tumour growth. It is licensed and can be prescribed in the UK for cancers like lung, bowel, breast and kidney.

But since Avastin has not yet been approved for use on the NHS by the National Institute for Health and Clinical Excellence (NICE), it is not widely available for NHS patients without health insurance.

Roche, the makers of Avastin, has now sponsored four clinical trials testing the drug for use in treating ovarian cancer.

The latest study, presented at the American Society of Clinical Oncology’s annual meeting in Chicago, involved 361 patients who had not responded to platinum-based chemotherapy.

All the patients were treated with a different type of chemotherapy, and half also received Avastin. The patients were followed for 13.5 months.

Researchers found that 75 per cent of the patients who received Avastin and chemotherapy had a cancer recurrence, compared to 91 per cent of patients receiving just chemotherapy.

The average time before the cancer started growing again after treatment became was 6.7 months in the Avastin group compared to 3.4 months.

Data on overall survival has not matured but is expected next year.

However, side effects such as high blood pressure and gastrointestinal perforations were greater in the Avastin group.

The study's lead author, Eric Pujade-Lauraine, the head of the Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, said the study findings are important because is the first time an improvement has been shown using a combination of drugs in women with platinum-resistant ovarian cancer.

© ActiveQuote Ltd. 2012

Categories:  Medical
Adding Avastin to chemotherapy helps slow ovarian cancer progressionAdding cancer drug Avastin to chemotherapy helps slow progression of ovarian cancer, according to a new study. Avastin is designed to shut     tweet it on twittershare with your friends on Facebookshare with your friends on MySpaceBlog it on your LinkedIn profile

No.1 health insurance broker as rated by customers

I found the quality of service to be very helpful, and pretty much above my expectation. I'd recommend anyone to use ActiveQuote.

Review centre member

Very helpful and polite and always try their best to obtain the best quotes. Have been using them for the last 3 years and will continue to use them in the future.

Review centre member

A great service from the initial call, to finalising the agreement. I would highly recommend to my family and friends.

Review centre member

Proactive, efficient, and offered me insurance I need. I would say half price I would end up paying if I did it by myself. Many thanks.

Review centre member

Excellent service. Explained everything in detail and really helped to find the right insurance best suited to my needs - which wasn't necessarily the most expensive. 

Review centre member

Good value and the advisor was very helpful and recommended the best policy for my grandson. I would definitely use this service again and recommend to others.

Review centre member

We were contacted in good time to make a knowledgable choice. We were given plenty of options with lots of information to enable us to make the right choice.

Review centre member

The service I received was excellent, the staff member was very efficient and knowledgable. She went out of her way to get the best policy for me.

Review centre member

Great service. I really appreciated the help provided by Active Quote to arrange health insurance. The agent was very informative and proactive. Many thanks!

Review centre member

I received excellent care and attention from the first phone call till the last. Friendly, efficient and patient.

Review centre member
This site is operated by Insurance Broker ActiveQuote Ltd registered in England & Wales company number 6765845.
Authorised and Regulated by the Financial Conduct Authority (FCA). Firm reference number 501109 as detailed on the Financial Services Register. Please read our Key Facts document.
For information about your rights as a consumer visit Citizens Advice.

Our insurance comparison service is free and easy for you to use, but you are responsible for making sure all your information is entered correctly, and for choosing your insurer.

This site uses cookies in order to work correctly - these are not harmful and do not contain personal information. By using this site you consent to this. I understand  Tell me more

please wait ...